Although one-third of US adults report using complementary and alternative medicine (CAM), integration of CAM into the conventional medical system is inconsistent. 1 Patients have shown a desire for their primary care physicians to inquire about CAM and refer to CAM practitioners (acupuncturist, massage therapists, etc), but primary care physicians rarely initiate conversations with patients about their use of CAM. 2, 3 Patients have also expressed concerns about discussing the use of CAM with their physicians, fearing disapproval. 4 These communication barriers may prevent CAM from becoming fully integrated into patients' treatment and self-care routines, especially if patients do not disclose their use of CAM to their primary care physicians. Using data from the 2012 National Health Interview Survey (NHIS), we identified patterns of CAM use in the United States and reasons for its nondisclosure from January 1 through December 31, 2012.
Methods | The NHIS is an annual survey conducted by the National Center for Health Statistics about health and health care use. The 2012 NHIS contains responses from 108 131 individuals in 42 366 households, of whom 34 525 adults completed the Sample Adult component and the Adult Alternative Medicine supplement. Our sample consists of 7493 civilian, noninstitutionalized US adults 18 years and older who completed the CAM supplement and indicated having used CAM during the past 12 months and having a personal primary care physician.
Respondents were asked whether they told their physician about using the CAM modality identified as most important to their health during the previous year. Those who did not were asked whether their nondisclosure was due to one of the following: (1) belief that their physician did not need to know about their CAM use, (2) past discouragement of CAM use by their physician, (3) potential discouragement of CAM use by their physician, (4) a potentially negative response from their physician, (5) doubts concerning their physician's knowledge about their most used CAM modality, (6) their physician not asking about CAM use, (7) not having time to discuss CAM use during visits with their physician, or (8) not using CAM at the time of their visit.
One-and 2-way tabulations were used to elucidate nondisclosure rates and reasons for nondisclosure according to respondents' most-used CAM modality. All analyses were weighted to be nationally representative and were done with Stata, version 11.2 (Stata Corp). All analyses were limited to pub-licly available, deidentified data, which does not meet the definition of human subjects research as determined by the University of Minnesota Institutional Review Board and therefore did not require board review.
Results | Of the 34 525 adults who completed the CAM supplement to the 2012 NHIS, 10 158 (29.6%) reported using CAM at least once in the past year, and 22 765 (66.3%) had a primary care physician. Of 7493 respondents who fit both criteria, 3094 (42.3%) did not disclose the use of their most used CAM modality ( Table 2) . Discussion | One-third of the US adult population use CAM; however, 42.3% of CAM users do not discuss CAM use with their primary care physicians. Contrary to earlier findings, our results attribute most nondisclosure to physicians not asking about CAM use or to concerns about physician knowledge regarding CAM rather than to physician discouragement or negativity about the use of CAM. Consequently, physicians should consider more actively inquiring about patients' use of CAM, especially for modalities likely to be medically relevant. Incorporating more education about CAM into medical curricula can better equip physicians to initiate conversations with
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Related article page 473 3, 4 Given the evidence for heterogeneity in screening practices, 5 we sought to compare the use of PSA testing among urologists vs primary care physicians (PCPs) before and after the latest USP-STF guidelines, hypothesizing that the adoption of these recommendations would vary according to physician specialty.
Methods | We used the National Ambulatory Medical Care Survey to examine the use of PSA testing in 2010 (conducted between December 28, 2009 , and December 26, 2010 ) and 2012 (conducted between December 28, 2011 , and December 26, 2012 . The National Ambulatory Medical Care Survey is an annual, nationally representative survey of ambulatory care in the United States that collects information about outpatient physician visits, patient demographics, diagnoses, medications, and indications for consultation. Specialty of health care professionals was dichotomized as urologist and PCP (general and family practice and internal medicine). We examined the frequency of PSA testing according to specialty and year to evaluate the association between the 2012 USPSTF recommendations and changes in PSA testing among men aged 50 to 74 years. Heterogeneity in testing practices between physicians was modeled by assessing the interaction term of physician specialty × survey year within a logistic regression model estimating probability of PSA testing. Results were weighted to reflect the US population based on the complex survey design. A 2-tailed level of significance was set at P < .05. The Brigham and Women's Hospital Institutional Review Board waived approval for the study. Data analysis was conducted from July 21 to November 16, 2015.
Results | We included all visits for men aged 50 to 74 years (n = 1222) who presented to urologists (113 [9.2%]) or PCPs (1109 [90.8%]) for a preventive care visit. Men with a diagnosis of prostate cancer (n = 18), elevated PSA level (n = 1), benign prostatic hyperplasia (n = 31), prostatitis (n = 5), or other unspecified disorders of the prostate (n = 3) were excluded. This exclusion resulted in a weighted sample of 27 million eligible visits (unweighted n = 1164) in 2010 and 2012, of which 800 000 (un- Editor's Note page 547
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